Access 2.8M+ Filings Sign Up Free
SynAct Pharma Logo

SynAct Pharma | SYNACT - Profile, Filings, Stock Info & Investor Relations Data

SynAct Pharma | SYNACT
Filings & Investor Relations Data
Login to Watchlist

Create a free account or log in.

Industry
Biotechnology
Country
Sweden
Founded
2012
SynAct Pharma (SYNACT)

Company Profile

Website
Investor Relations

About SynAct Pharma

SynAct Pharma is a clinical stage biotechnology company focused on resolving inflammation with melanocortin biology. Selective activation of the melanocortin system can help the immune system resolve excessive or chronic inflammation. SynAct’s therapeutics are designed to selectively provide anti-inflammatory and pro-resolution effects, so that patients can achieve immune balance and live beyond their inflammation.

AP1189, our product candidate selectively stimulates the melanocortin receptors involved in anti-inflammatory and pro-resolution effects without causing immunosuppression that is associated with most of the available anti-inflammatory therapies. These immunosuppressive approaches can lead to opportunistic infections and other serious side effects.

Market Presence

Worldwide

Headquarters

Scheelevägen 2
223 63, Lund
Sweden

SynAct Pharma (SYNACT)
Key Financial Data

AI-Powered Financial Insights Coming Soon

We are currently processing the filings for this company to provide automated financial statement analysis, key ratios, and risk summaries. Please check back later!

Unlock Full Company Insights & AI Chat

Create a free account or log in to add companies to your watchlist, access more data, and chat directly with filings using our AI assistant (as shown!).

Create Free Account Sign In

SynAct Pharma (SYNACT)
Filings & Annual Reports
Chat with AI, summarize, and extract data from processed filings! Look for the 'View & AI' button.

Quick Filters:

Advanced Filters

View all types
Filing Information Actions

Insider Trading Activity

↑
Anders Kronborg (Other)
Buy SEK 250,002.30 SEK 8.65 30.12.24
◆
Björn Westberg (Other)
Other SEK 0.00 SEK 0.00 01.06.24
◆
Jeppe Øvlesen (Other)
Other SEK 499,995.40 SEK 8.60 30.04.24
◆
Anders Kronborg (Other)
Other SEK 299,993.80 SEK 8.60 30.04.24
◆
Jeppe Øvlesen (Other)
Other SEK 1,696,503.00 SEK 6.90 21.03.24
◆
Thomas Jonassen (Other)
Other SEK 22,072,775.00 SEK 6.25 09.11.23
◆
Thomas Jonass (Other)
Other SEK 13,507,656.25 SEK 6.25 09.11.23
◆
Jeppe Øvlesen (Other)
Other SEK 72,727,240.20 SEK 62.60 16.01.23
◆
James Knight (Other)
Other SEK 4,848,495.20 SEK 62.60 16.01.23
◆
Thomas Boesen (Other)
Other SEK 2,060,604.20 SEK 62.60 16.01.23

SynAct Pharma (SYNACT)
Stock & Investor Information

ISINs

SE0008241491
SE0023441027

LEI

549300RRYIEFEQ72N546

Stock Exchange Listings

Nasdaq Stockholm

Industry Classification

Sector
Health Care
Industry
Biotechnology